SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-119573
Filing Date
2021-04-16
Accepted
2021-04-16 17:19:53
Documents
6
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT d151412dpre14a.htm PRE 14A 423938
2 GRAPHIC g151412g08h41.jpg GRAPHIC 23601
3 GRAPHIC g151412g25h31.jpg GRAPHIC 34435
4 GRAPHIC g151412g48i45.jpg GRAPHIC 57288
5 GRAPHIC g151412page001.jpg GRAPHIC 195846
6 GRAPHIC g151412page002.jpg GRAPHIC 97740
  Complete submission text file 0001193125-21-119573.txt   988349
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39045 | Film No.: 21832403
SIC: 2834 Pharmaceutical Preparations